Interim Order No. 2 respecting clinical trials for medical devices and drugs ...
IO No. 2 continues to support the optional pathway introduced by IO No. 1 to facilitate clinical trials for potential COVID-19 drugs and medical devices.
Organization:
Health Canada
Resource Formats:
- HTML